![[SEBASTIAN KAULITZKI] - STOCK.ADOBE.COM](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3fbe7b21eef28f23798900792090beea0407b955-950x1030.png?w=350&fit=crop&auto=format)
Determining treatment options for patients with locally advanced rectal cancer after the PROSPECT trial data readout adds an important level to the decision-making process.
Manju George, PhD
Advertisement
Articles by Manju George, PhD
Advertisement
Latest Updated Articles
![[SEBASTIAN KAULITZKI] - STOCK.ADOBE.COM](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3fbe7b21eef28f23798900792090beea0407b955-950x1030.png?w=300&fit=crop&auto=format)
Advertisement
Advertisement
Trending on CancerNetwork
1
58 An Evidence-Based Self-Management Planner for Patients With Metastatic Triple-Negative Breast Cancer: A Multi-Channel Dissemination Initiative
2
3 Things You Should Know About Using Selective Estrogen Receptor Degraders in Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
3
57 Altered Biomechanics Drives Outcome in Breast Cancer: A New Avenue for Oncology Biomarkers
4
From Conference to Practice: Top 5 Takeaways From EHA 2026
5